Heart |
Decrease cardiac hypertrophy in hypertension |
|
Improve cardiac contractility in ischemic heart |
|
Prevent cardiac injury in cardiac ischemia/reperfusion |
|
Inhibit local renin-angiotensin system |
Blood vessels |
Increase vasorelaxation in response to vasodilators |
|
Decrease vasoconstriction in response to vasoconstrictors |
|
Decrease vascular growth in hypertension |
Kidney |
Increase diuresis and natriuresis |
|
Maintain normal renal excretory function |
|
Decrease renal injury with advancing age |
|
Improve renal function in hypertension |
Brain |
Restore norepinephrine content in hypothalamus and rostral ventrolateral medulla (RVLM) |
|
Attenuate pressor effects of angiotensin II at RVLM |
|
Improve baroreflex sensitivity in hypertension |
|
Direct antihypertension as a neuromodulator |
Autonomic nervous system |
Decrease sympathetic outflow in hypertension via hypothalamus and RVLM |
|
Decrease norepinephrine release from peripheral sympathetic nerves |
Renin-angiotensin system |
Inhibit renin-angiotensin system overactivity in hypertension |
|
Inhibit angiotensin II-induced cardiac hypertrophy |
Glucose-insulin regulation |
Increase insulin secretion |
|
Increase tissue glucose uptake |
|
Improve insulin resistance in sugar-induced hypertension |
Antioxidant |
Convert superoxides to taurochloramine |
|
Increase serum NO and NO synthase activity |